Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells (vol 28, pg 2155, 2014)

被引：15
|
作者：
Fiskus, W.
Sharma, S.
Shah, B.
Portier, B. P.
Devaraj, S. G. T.
Liu, K.
Iyer, S. P.
Bearss, D.
Bhalla, K. N.
机构：
来源：
LEUKEMIA | 2017年 / 31卷 / 07期
关键词：
D O I：
10.1038/leu.2017.77
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Correction to: Leukemia (2014) 28, 2155–2164; doi:10.1038/leu.2014.119; published online 25 April 2014 Following the publication of this article, the authors noted that the loading control (β-actin) for the primary AML cells data presented in Figure 7b was incorrect. The correct western blot for theloading control (β-actin) has been added to Figure 7b.
引用
收藏
页码：1658 / 1658
页数：1
相关论文
共 18 条
  • [1] Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
    W Fiskus
    S Sharma
    B Shah
    B P Portier
    S G T Devaraj
    K Liu
    S P Iyer
    D Bearss
    K N Bhalla
    Leukemia, 2014, 28 : 2155 - 2164
  • [2] Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
    Fiskus, W.
    Sharma, S.
    Shah, B.
    Portier, B. P.
    Devaraj, S. G. T.
    Liu, K.
    Iyer, S. P.
    Bearss, D.
    Bhalla, K. N.
    LEUKEMIA, 2014, 28 (11) : 2155 - 2164
  • [3] Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
    W Fiskus
    S Sharma
    B Shah
    B P Portier
    S G T Devaraj
    K Liu
    S P Iyer
    D Bearss
    K N Bhalla
    Leukemia, 2017, 31 : 1658 - 1658
  • [4] Pre-Clinical Efficacy of Combined Therapy with LSD1 Antagonist SP-2509 and Pan-Histone Deacetylase Inhibitor Against AML Blast Progenitor Cells
    Fiskus, Warren
    Sharma, Sunil
    Abhyankar, Sunil
    McGuirk, Joseph
    Bearss, David J.
    Bhalla, Kapil
    BLOOD, 2012, 120 (21)
  • [5] Combined targeting of LSD1 (KDM1A) and histone deacetylases exerts superior efficacy against human AML
    Fiskus, Warren
    Sharma, Sunil
    Rao, Rekha
    Balusu, Ramesh
    Venkannagari, Sreedhar
    Ganguly, Siddhartha
    Bearss, David
    Bhalla, Kapil N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human AML.
    Bhalla, Kapil N.
    Fiskus, Warren
    Peth, Karissa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
    Rao, Rekha
    Balusu, Ramesh
    Fiskus, Warren
    Mudunuru, Uma
    Venkannagari, Sreedhar
    Chauhan, Lata
    Smith, Jacqueline E.
    Hembruff, Stacey L.
    Ha, Kyungsoo
    Atadja, Peter
    Bhalla, Kapil N.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) : 973 - 983
  • [8] Pre-Clinical Efficacy of Co-Treatment with KDM1A (LSD1) Inhibitor and Ruxolitinib or BET Inhibitor Against Post-MPN-sAML Blast Progenitor Cells
    Fiskus, Warren
    Mill, Christopher Peter
    Karkhanis, Vrajesh
    Lara, Bernardo H.
    Bose, Prithviraj
    Masarova, Lucia
    Kadia, Tapan M.
    Shao, Nancy
    Bhalla, Isean
    Maher, James V.
    Khoury, Joseph D.
    Sharma, Sunil
    Manshouri, Taghi
    Verstovsek, Srdan
    Bhalla, Kapil N.
    BLOOD, 2019, 134
  • [9] BRD4 Antagonist and Histone Deacetylase Inhibitor: A Novel Synergistic Combination Against Human Acute Myeloid Leukemia (AML) Cells
    Fiskus, Warren
    Sharma, Sunil
    Qi, Jun
    Valenta, John A.
    Schaub, Leasha J.
    Shah, Bhavin
    Pethi, Karissa
    Jakkula, Laxmi U. M. R.
    Rodriguez, Melissa
    Devaraj, Santhana
    Iyer, Swaminathan Padmanabhan
    Bradner, James E.
    Bhalla, Kapil N.
    BLOOD, 2013, 122 (21)
  • [10] Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
    Fiskus, Warren
    Sharma, Sunil
    Qi, Jun
    Valenta, John A.
    Schaub, Leasha J.
    Shah, Bhavin
    Peth, Karissa
    Portier, Bryce P.
    Rodriguez, Melissa
    Devaraj, Santhana G. T.
    Zhan, Ming
    Sheng, Jianting
    Iyer, Swaminathan P.
    Bradner, James E.
    Bhalla, Kapil N.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) : 1142 - 1154
12